By Dr. Sanchari Sinha Dutta, Ph.D. New research uncovers how distinct molecular profiles and immune signatures in metastatic ...

From jaundice and uncontrolled blood sugars to cancer concerns, each scenario highlights the importance of patient education ...

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective ...

The American Cancer Society's annual cancer trend report shows cancer mortality is decreasing but cancer rates are increasing in young adults and women.

Pancreatic cancer is generally characterized by a poor prognosis. Patients with lung-metastatic pancreatic ductal adenocarcinoma survive longer than those with liver metastases. A study now ...

Oncolytics Biotech received approval from Germany\u2019s Paul-Ehrlich-Institute to advance Cohort 5 of the GOBLET study, ...

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute and there are few effective treatment options for the disease. In a new study, researchers at the University ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

and death and is known to be the primary driver of pancreatic tumor growth and the spread of the cancer to other tissues in the body. Silencing the MICAL2 gene in PDAC cells dramatically slowed ...